Apalutamide and Overall Survival in Prostate Cancer

Smith, MR; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; De Porre, P; Smith, AA; Brookman-May, SD; Li, S; Zhang, K; Rooney, B; Lopez-Gitlitz, A; Small, EJ

Smith, MR (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Yawkey 7030,55 Fruit St, Boston, MA 02114 USA.; Smith, MR (corresponding author), Harvard Med Sch, Yawkey 7030,55 Fruit St, Boston, MA 02115 USA.

EUROPEAN UROLOGY, 2021; 79 (1): 150

Abstract

Background: The phase 3 SPARTAN study evaluated apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC......

Full Text Link